Business · 08/05/2020Updated: 10/17/2026 · 1 min read
FDA Announces Final Guidance for Industry on Cytomegalovirus in Transplantation
Summary
The FDA has released a final guidance to help pharmaceutical companies develop drugs to treat or prevent cytomegalovirus disease in transplant patients, following a draft issued in 2018.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →